204 results on '"Cicinnati, V"'
Search Results
2. Pre-Transplantation MAnagement Issue
3. DEVELOPMENT OF A MODEL FOR ESTIMATION OF SUBCUTANEOUS HEPATITIS B IMMUNOGLOBULIN DOSE REQUIREMENT AFTER LIVER TRANSPLANTATION: V38
4. ENDOSCOPIC ULTRASOUND FOR THE DIAGNOSIS OF BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION: V10
5. ABC-Transporter Gene Polymorphisms- Risk Factor for Biliary Complications in Liver Transplant Recipients.: Abstract# C1970
6. Donor Specific Antibodies Against HLA Class II and C4d-Positivity: Risk Factors for Liver Allograft Fibrosis.: Abstract# 675
7. Body Weight May Not Be Sufficient for Reliable Estimation of Subcutaneous Hepatitis B Immunoglobulin Dose Requirement
8. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope
9. Transhilar Passage in Right Graft Live Donor Liver Transplantation: Intrahilar Anatomy and Its Impact on Operative Strategy
10. BILIARY STRICTURES FOLLOWING LIVER TRANSPLANTATION: ROLE OF CHEMOKINE RECEPTOR POLYMORPHISMS, DONOR-SPECIFIC ANTI-HLA ANTIBODIES AND SERUM CYTOKINE PROFILE: 218
11. Alloreactivity in Recipients Prior to and Post Living Kidney and Liver Transplantation
12. Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients
13. Patient Evaluation
14. Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients – assessment of renal and allograft function, cardiovascular risk factors and immune monitoring
15. Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation
16. Tuberculosis and liver transplantation*: P-259
17. Follow-up of non-HLA and anti-HLA antibodies: Importance in graft failure after liver transplantation
18. Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neoplasms
19. Evaluation of fibrotic liver disease with whole-liver T1rho MR imaging: A feasibility study at 1.5 T
20. FRI-051 - Follow-up of non-HLA and anti-HLA antibodies: Importance in graft failure after liver transplantation
21. P0077 : Improvement of liver elasticity in HCV-patients under sofosbuvir-based therapy after liver transplantation
22. P0475 : Post-liver transplant fibrosis allograft progression is associated with increased levels of soluble NKG2D ligands
23. Stellenwert des FDG-PET in der Diagnostik von hepatozellulären Karzinomen
24. Patient Evaluation
25. Long-Term Complications After Liver Transplalntation
26. Pre-Transplantation MAnagement Issue
27. Stellenwert der Endosonografie bei der Diagnostik biliärer Komplikationen nach Lebertransplantation
28. Mikrobielle Analyse von Galle sowie Stuhl lebertransplantierter Patienten und deren Einfluss auf das Management septischer Komplikationen nach ERCP
29. ABC-Transporter Gene Polymorphisms - Risk Factor for Biliary Complications in Liver Transplant Recipients.
30. Donor Specific Antibodies Against HLA Class II and C4d-Positivity: Risk Factors for Liver Allograft Fibrosis.
31. Complicated gastrointestinal CMV disease after small bowel transplantation
32. 1407 TTR MUTATIONS IN GERMAN PATIENTS WITH FAMILIAL AMYLOID POLYNEUROPATHY
33. Use of paclitaxel-eluting balloons for endotherapy of anastomotic strictures following liver transplantation
34. Role of ATP-Binding Cassette Transporter Gene Polymorphisms and Metabolic Risk Factors for Allograft Fibrosis after Liver Transplantation
35. Soluble Ligands for Activating Natural Killer Receptor (NKG2D) Are Biomarkers for Progression of Hepatic Fibrosis after Liver Transplantation
36. Endoscopic Treatment of Anastomotic Strictures after Liver Transplantation Using Paclitaxel-Coated Balloons
37. 550 GENETIC POLYMORPHISMS OF ABCG5/8 AND ABCB1 AND THEIR IMPACT AFTER LIVER TRANSPLANTATION
38. 695 POLYMORPHISMS OF FRACTALKINE RECEPTOR AND IMMUNOLOGIC RISK FACTORS FOR ANASTOMOSIS STENOSIS AFTER LIVER TRANSPLANTATION
39. Mycophenolic acid, a possible Inhibitor of re-fibrosis in HCV-positive liver transplanted patients
40. HEPATITIS B SPECIFIC IMMUNE TRANSFER IN AB0 INCOMPATIBLE LIVING DONOR LIVER TRANSPLANTATION*
41. DECREASED EXPRESSION OF MIR-199A-5P CONTRIBUTES TO INCREASED CELL INVASION BY FUNCTIONAL DEREGULATION OF DDR1 ACTIVITY IN HEPATOCELLULAR CARCINOMA
42. TWENTY YEARS EXPERIENCE IN LIVE DONOR LIVER TRANSPLANTATION: THE EVOLUTION OF THE “CARVING” LIVER TRANSACTION TECHNIQUE
43. EFFECT OF MDR1 AND ABCG8 POLYMORPHISMS ON HEPATITIS C RECURRENCE FOLLOWING LIVER TRANSPLANTATION
44. TRANSIENT ELASTOGRAPHY AND DEVELOPMENT OF A NON-INVASIVE MULTIPARAMETER SCORE FOR ASSESSMENT OF ALLOGRAFT FIBROSIS IN LIVER TRANSPLANT PATIENTS
45. TRANS-HILAR PASSAGE IN RIGHT GRAFT LIVE DONOR LIVER TRANSPLANTATION: INTRA-HILAR ANATOMY AND ITS IMPACT ON OPERATIVE STRATEGY
46. SINGLE NUCLEOTIDE POLYMORPHISMS OF CHEMOKINE RECEPTORS AND ATP-BINDING CASSETTE TRANSPORTER AND RISK OF BILIARY STRICTURES AFTER LIVER TRANSPLANTATION
47. THE VENOUS DRAINAGE PATTERNS BETWEEN THE RIGHT- (RHV) AND ACCESSORY (IHV) HEPATIC VEINS: ANATOMICAL-FUNCTIONAL CLASSIFICATION DERIVED FROM 3-DIMENSIONAL CT RECONSTRUCTIONS.
48. Role of microRNA-199a-5p and discoidin domain receptor 1 for human hepatocellular carcinoma invasion
49. Role of chemokine receptor and ATP-binding cassette transporter gene polymorphisms for biliary lesions following liver transplantation
50. Efficacy of liver stiffness measurement and biochemical tests to assess severe fibrosis in patients transplanted for non-HCV related liver diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.